TÍCH TÌNH HÌNH SỬ DỤNG THUỐC THUỶ CHÂM: NGHIÊN CỨU TẠI BỆNH VIỆN CHÂM CỨU TRUNG ƯƠNG NĂM 2022

Abstract

Objectives: Medicines used by the hypo-acupuncture (HA) are one of the specialized treatment methods at the National Hospital of Acupuncture (NHA). This study aimed to analyze the utilization of HA medicines at the NHA in 2022, focusing on quantity, structure, cost, and the reimbursement rate by Social Health Insurance (SHI). Materials and methods: A cross-sectional descriptive study using retrospective data on the quantity and cost of HA medicines. Medicines were analyzed by pharmacological groups, structure, and SHI reimbursement rates. Data was processed and analyzed using Microsoft Excel. Results: In 2022, a total of 124,725 ampoules of HA medicines with a value of 460 million VND were utilized, but only 16% of the cost was covered by SHI. The main medicine groups included: Minerals and vitamins accounted for 45.78% of the total cost; Vincozyn Plus was the most used medicine (75,702 ampoules); Psychotropic and neurological medicines accounted for 54.22% of the total cost, with Cerebrolysin and Methycobal being the most common. Only 08 medicines were used, of which 04 were fully reimbursed by SHI, 03 were conditionally reimbursed, and 01 was not listed under SHI coverage. Conclusion: The SHI reimbursement rate for HA medicines remains low due to policy changes and the lack of approved treatment guidelines. The hospital needs to develop treatment protocols for HA medicines tailored to the major diseases in its case mix and submit them for approval by relevant authorities. Furthermore, the hospital should collaborate with relevant departments and agencies to propose full HI reimbursement for hypodermic acupuncture medicines in accordance with the approved treatment protocols of the hospital and the traditional medicine sector.